Study guide

9.4 The Utah Controlled Substance Database (CSD)

Utah MPJE Pharmacy Jurisprudence Exam

Track your progress as you read

Finished sections get a check mark.

1 Chapter 1: Utah Pharmacy Regulatory Framework, Facility Licensing & the PIC

1.1 DOPL, the Utah State Board of Pharmacy & the Sources of Utah Pharmacy Law 1.2 Federal vs. Utah Law: Following the Stricter Standard 1.3 Utah Pharmacy License Classes (A–E) & Facility Licensing 1.4 The Pharmacist-in-Charge (PIC): Duties, Self-Audits & Notifications 1.5 Facility Inspections, Ownership & Location Changes, Closing & Facility Discipline

2 Chapter 2: Pharmacist, Intern & Technician Licensure and Personnel

2.1 Pharmacist Licensure, the NAPLEX & Utah MPJE, and Licensure by Endorsement 2.2 License Renewal, Continuing Education & Reinstatement 2.3 Pharmacy Interns & Preceptors 2.4 Pharmacy Technicians, Technician Trainees & Supportive Personnel

3 Chapter 3: Unlawful & Unprofessional Conduct, Discipline, and Impairment

3.1 Unlawful Conduct, Criminal Penalties, Fines & the Disciplinary Process 3.2 Unprofessional Conduct, the APhA Code of Ethics & Utah's Conscience Law 3.3 Impairment, the Utah Professionals Health Program & Reinstatement

4 Chapter 4: Prescription Issuance, Prescriber Authority & Electronic Prescribing

4.1 Prescriber Scope of Authority in Utah 4.2 Required Prescription Elements, Oral & Faxed Orders, and Alterations 4.3 Mandatory Electronic Prescribing of Controlled Substances (EPCS) in Utah 4.4 Legitimate Medical Purpose, Corresponding Responsibility & Red Flags

5 Chapter 5: Patient Counseling, Prospective DUR, Confidentiality & Records

5.1 Patient Counseling: The Offer, Who May Counsel & Delivered Prescriptions 5.2 Prospective Drug Utilization Review & Patient Medication Profiles 5.3 Confidentiality, HIPAA & Protected Health Information 5.4 Pharmacy Records, Retention Periods & Facility Operating Standards

6 Chapter 6: Expanded Practice: Collaboration, Pharmacist Prescribing & Drug Administration

6.1 Collaborative Pharmacy Practice, Drug Therapy Management & Administration of Drugs 6.2 Self-Administered Hormonal Contraception: Standing Order & Pharmacist Prescribing 6.3 Pharmacist Prescribing Under Utah Code § 58-17b-627: Tobacco Cessation, HIV PrEP/PEP, Fluoride & Epinephrine 6.4 Vaccine Administration: DOPL's Protocol, Delegation, Emergencies & USIIS Reporting

7 Chapter 7: Opioid Overdose Prevention, Emergency Refills & Returned or Donated Drugs

7.1 Naloxone & Opioid-Safety Laws in Utah 7.2 Emergency Refills, Combined Refills & Insulin Continuity 7.3 Returned Drugs, Consumer Disposal & the Charitable Prescription Drug Recycling Program

8 Chapter 8: Controlled Substance Schedules, Registration & Security in Utah

8.1 Controlled Substance Schedules: Federal CSA & Utah-Specific Scheduling 8.2 DEA Registration & Facility Licensing 8.3 Controlled Substance Storage & Physical Security

9 Chapter 9: Dispensing Controlled Substances & the Utah Controlled Substance Database

9.1 Schedule II Prescriptions: 30-Day Window, One-Month Supply, Multiple Prescriptions & the 7-Day Acute Limit 9.2 Schedule II Partial Fills, Emergency Oral Orders & Methadone Emergency Orders 9.3 Schedule III–V Prescriptions: Refill Limits, the 80% Rule & Controlled Substance Transfers 9.4 The Utah Controlled Substance Database (CSD)

10 Chapter 10: Dispensing Standards: Labeling, Substitution, Refills, Packaging, Product Integrity & OTC Products

10.1 Prescription Labels: Utah Minimum Elements, Controlled Substance & Opioid Warnings, and Special Labels 10.2 Drug Product Selection: Generic Equivalents, Therapeutically Similar Drugs & Interchangeable Biologics 10.3 Legend-Drug Prescription Validity, Refills & Transfers 10.4 Poison Prevention Packaging Act (PPPA) & Special Packaging 10.5 Drug Product Conditions That Prohibit Dispensing: Adulterated, Misbranded, Outdated, Recalled & Suspect Products 10.6 Nonprescription Products: OTC Labeling & Packaging, Pseudoephedrine, Iodine, Schedule V & Other Restricted OTC Sales

11 Chapter 11: Acquisition, Inventory, Loss, Distribution & Delivery

11.1 Ordering Schedule II Substances: DEA Form 222 & CSOS 11.2 Controlled Substance Inventories & Utah's Schedule II Perpetual Inventory 11.3 Theft, Significant Loss & Disposal of Controlled Substances 11.4 Drug Acquisition & Distribution, Office-Use Sales, and Delivering Prescriptions to Patients

12 Chapter 12: Compounding Standards, USP Chapters & Hazardous Drugs

12.1 Non-Sterile Compounding & USP <795> Standards 12.2 Sterile Compounding & USP <797> Standards 12.3 Hazardous Drug Handling & USP <800> Standards

13 Chapter 13: Institutional, Central Processing, Remote Dispensing, Specialty Outlets & Automation

13.1 Institutional Practice: Hospitals, Pharmaceutical Administration Facilities & Emergency Drug Kits 13.2 Centralized Prescription Processing, Telepharmacy & Remote Dispensing Pharmacies 13.3 Nuclear Pharmacies, Class E Outlets & Dispensing Medical Practitioners 13.4 Automated Pharmacy Systems, Quality Assurance & Pharmacy Audits

9.4 The Utah Controlled Substance Database (CSD)

Key Takeaways Explain This Topic AI

Utah pharmacies must submit controlled substance dispensing data to the CSD daily, either in real time or by 24-hour daily or next-business-day batch, whichever is later (Utah Code § 58-37f-203; R156-37f-203).

A Utah pharmacy with a controlled substance license that dispensed nothing since its last submission must send a zero report, unless DOPL has approved a waiver or certification that is renewed each year.

A Utah prescriber must check the CSD before first prescribing a Schedule II or III opioid to a patient and review it periodically during repeated prescribing (Utah Code § 58-37f-304(2)).

Knowingly and intentionally releasing CSD information in violation of the access limits is a third degree felony in Utah (Utah Code § 58-37f-601).

A Utah pharmacy or PIC that fails to submit required CSD data after a written request, or shows a pattern of non-submission, faces a civil penalty of up to $1,000 per unreported prescription (Utah Code § 58-37f-602).

Last updated: September 2026

9.4 The Utah Controlled Substance Database (CSD)

Blueprint item 3.3 specifically includes "requirements for reporting to PMP and accessing PMP data." Utah's PMP is the Controlled Substance Database (CSD) , created by Title 58, Chapter 37f and administered by DOPL under R156-37f .

What must be reported

The PIC and the pharmacist of the outlet where a controlled substance is dispensed must submit the data (§ 58-37f-203(2)). A dispensing medical practitioner takes on the pharmacist's duty.

The data covers each controlled substance dispensed and any noncontrolled substance DOPL designates by rule (§ 58-37f-203(3)). Gabapentin was collected as a designated noncontrolled drug starting in 2019 and has been a Utah Schedule V drug since 2024. The rule also calls out butalbital (R156-37f-203(7)–(8)).

Exception: drugs dispensed for administration to, or use by, a patient at a health care facility , including an outpatient setting at the facility, are not reported (§ 58-37f-203(3)(b)).

Hospital and ED dispensing of controlled substances to patients leaving the facility is reported through the appropriate pharmacy (R156-17b-610.5(4); R156-17b-610.6(3)).

When and how

Requirement Rule

Frequency Daily , either real-time or 24-hour daily or next-business-day batch, whichever is later (§ 58-37f-203(1); R156-37f-203(1))

Date basis The point-of-sale date , meaning the date the drug left the pharmacy (R156-37f-102(12))

Order Chronological by date sold. Groups sort by individual pharmacy.

Format ASAP Version 4.2 , by secure internet transfer (for example, sFTP), a secure web service, or another approved electronic method

Corrections Within seven business days after DOPL notifies the pharmacist that data is incomplete or wrong (§ 58-37f-203(1)(c))

Zero report Required if no reportable controlled substance was dispensed since the last submission (R156-37f-203(5))

Waiver A Class A, B, D, or E pharmacy with a CS license that isn't dispensing controlled substances may use a DOPL-approved waiver or certification instead of daily zero reports, renewed each calendar year . It ends automatically on the first CS dispensing, and DOPL must be notified within 24 hours or the next business day.

Required data includes the pharmacy's NPI and NCPDP or DEA number; the patient's name, address, ZIP code, and date of birth; the prescription number, date written, refills authorized, fill date, and refill number; the NDC, quantity, and days' supply; the date sold ; the prescriber's DEA number ; the identification of the person picking up the prescription (ID type, number, issuing state, and name); and the dispensing pharmacist (R156-37f-203(4)).

Who may access the CSD (§ 58-37f-301)

Access is limited to categories listed in statute, including:

pharmacists with authority to dispense controlled substances, and interns and technicians under a pharmacist's general supervision , for dispensing or considering dispensing, detecting fraud, reporting, or verifying submitted data;

prescribers , for current or prospective patients, suspected fraud, and review of their own prescribing, plus designated employees DOPL approves after a background check;

law enforcement and prosecutors with a valid search warrant in a controlled-substance investigation of a specific person (DOPL may also give limited non-identifying information in joint investigations);

DOPL investigators and analysts, board members monitoring a licensee on probation, UPHP staff, DHHS for authorized studies and suspected improper acquisition, the medical examiner, Medicaid integrity and fraud units, probation and parole officers supervising a specific person, and others the statute lists; and

the patient , who may see their own records and a list of who has requested them, unless under investigation. Patients may request corrections, which DOPL decides within 30 days.

Query duties

Prescribers must register with the CSD, completing an online tutorial and test that must be answered 100% correctly (§§ 58-37f-401, -402). They must check the database before the first time they prescribe a Schedule II or III opioid to a patient, and periodically when prescribing repeatedly (§ 58-37f-304(2)). Prescribers of high-risk prescriptions must also check for other active high-risk prescriptions (§ 58-37-305).

Dispensers: Utah does not require a query before every fill. If a dispenser's CSD review suggests a person may be obtaining opioids in quantities or frequencies inconsistent with accepted standards, the dispenser shall reasonably attempt to contact the prescriber (§ 58-37f-304(4)).

Section 58-37f-304 does not establish a minimum standard of care (§ 58-37f-701(2)).

Immunity and penalties

A person who submits information to, or accesses and reviews, the database under the chapter may not be held civilly liable for doing so, or for not acting on it (§ 58-37f-701).

Misuse: knowingly releasing database information in violation of Part 3 is a third degree felony . Negligent or reckless release is a class C misdemeanor . Obtaining information by misrepresentation, or for an unauthorized purpose, is a third degree felony . Each knowing unauthorized use or release is also subject to a civil penalty of up to $5,000 (§ 58-37f-601).

Failure to submit: after a specific written request, or when there is a pattern of non-submission, DOPL may discipline the PIC or pharmacy and impose a civil penalty of up to $1,000 per dispensed prescription not reported (§ 58-37f-602). Failing to submit after written notice is also unprofessional conduct (R156-37-502(8)), and the PIC must ensure timely submission (R156-17b-603(3)(p)).